Header Logo

Connection

David Driscoll to Humans

Back to Details
This is a "connection" page, showing publications David Driscoll has written about Humans.
David Driscoll
Connection Strength
0.536
Humans
  1. Driscoll DF, Bistrian BR. Cytokine Release Syndrome Associated With Immune-Modulating Chemotherapy: Potential Mitigating Role of Intravenous Omega-3 Fatty Acid Triglycerides. Cancer Rep (Hoboken). 2024 Oct; 7(10):e70025.
    View in: PubMed
    Score: 0.036
  2. Driscoll DF, Bistrian BR. Pharmaceutical Considerations and Metabolic Fate of Parenteral Lipid Nanoparticle Dosage Forms. J Pharm Sci. 2024 Aug; 113(8):2560-2564.
    View in: PubMed
    Score: 0.035
  3. Driscoll DF. Lipid nanoparticle-based COVID-19 vaccines: Ensuring pharmaceutical stability, safety, and efficacy. Am J Health Syst Pharm. 2023 12 05; 80(24):1847-1849.
    View in: PubMed
    Score: 0.034
  4. Driscoll DF, Bistrian BR. Cytokine storm associated with severe COVID-19 infections: The potential mitigating role of omega-3 fatty acid triglycerides in the ICU. FASEB J. 2023 08; 37(8):e23066.
    View in: PubMed
    Score: 0.033
  5. Driscoll DF. Proinflammatory mediators in lipid emulsions and parenteral nutrition-associated liver disease: Review of leading factors. JPEN J Parenter Enteral Nutr. 2023 08; 47(6):710-717.
    View in: PubMed
    Score: 0.033
  6. Driscoll DF. Lipid nanoparticle-based COVID-19 vaccines: Concerns about stability. Am J Health Syst Pharm. 2022 09 07; 79(18):1514-1515.
    View in: PubMed
    Score: 0.031
  7. Welty F, Bistrian B, Driscoll D. Omega-3 Fatty Acids Effect on Major Cardiovascular Events in Patients at High Cardiovascular Risk. JAMA. 2021 04 06; 325(13):1333.
    View in: PubMed
    Score: 0.028
  8. Driscoll DF. Pharmaceutical and Clinical Aspects of Lipid Injectable Emulsions. JPEN J Parenter Enteral Nutr. 2017 01; 41(1):125-134.
    View in: PubMed
    Score: 0.021
  9. Driscoll DF. Commercial lipid emulsions and all-in-one mixtures for intravenous infusion - composition and physicochemical properties. World Rev Nutr Diet. 2015; 112:48-56.
    View in: PubMed
    Score: 0.018
  10. Driscoll DF. Assessment of the physicochemical stability of all-in-one parenteral emulsions for neonates according to USP specifications, Athanasiou et al. JPEN J Parenter Enteral Nutr. 2014 Sep; 38(7):775-7.
    View in: PubMed
    Score: 0.018
  11. Driscoll DF, Newton DW, Bistrian BR. Potential hazards of precipitation associated with calcium chloride in parenteral nutrition admixtures: response to Migaki et al. JPEN J Parenter Enteral Nutr. 2012 Sep; 36(5):497-8; author reply 498-500.
    View in: PubMed
    Score: 0.015
  12. Driscoll DF, Silvestri AP, Bistrian BR. Stability of MCT/LCT-based total nutrient admixtures for neonatal use over 30 hours at room temperature: applying pharmacopeial standards. JPEN J Parenter Enteral Nutr. 2010 May-Jun; 34(3):305-12.
    View in: PubMed
    Score: 0.013
  13. Joy J, Silvestri AP, Franke R, Bistrian BR, Nehne J, Newton DW, Driscoll DF. Calcium and phosphate compatibility in low-osmolarity parenteral nutrition admixtures intended for peripheral vein administration. JPEN J Parenter Enteral Nutr. 2010 Jan-Feb; 34(1):46-54.
    View in: PubMed
    Score: 0.013
  14. Driscoll DF, Thoma A, Franke R, Kl?tsch K, Nehne J, Bistrian BR. Lipid globule size in total nutrient admixtures prepared in three-chamber plastic bags. Am J Health Syst Pharm. 2009 Apr 01; 66(7):649-56.
    View in: PubMed
    Score: 0.012
  15. Singh H, Dumas GJ, Silvestri AP, Young S, Martin CR, Bistrian BR, Driscoll DF. Physical compatibility of neonatal total parenteral nutrition admixtures containing organic calcium and inorganic phosphate salts in a simulated infusion at 37 degrees C. Pediatr Crit Care Med. 2009 Mar; 10(2):213-6.
    View in: PubMed
    Score: 0.012
  16. Driscoll DF. Pure long-chain triglyceride emulsion exhibited physicochemical stability in parenteral all-in-one admixtures for neonates. JPEN J Parenter Enteral Nutr. 2009 Jul-Aug; 33(4):451-2.
    View in: PubMed
    Score: 0.012
  17. Driscoll DF. The pharmacopeial evolution of intralipid injectable emulsion in plastic containers: from a coarse to a fine dispersion. Int J Pharm. 2009 Feb 23; 368(1-2):193-8.
    View in: PubMed
    Score: 0.012
  18. Driscoll DF, Bistrian BR, Demmelmair H, Koletzko B. Pharmaceutical and clinical aspects of parenteral lipid emulsions in neonatology. Clin Nutr. 2008 Aug; 27(4):497-503.
    View in: PubMed
    Score: 0.012
  19. Newton DW, Driscoll DF. Calcium and phosphate compatibility: revisited again. Am J Health Syst Pharm. 2008 Jan 01; 65(1):73-80.
    View in: PubMed
    Score: 0.011
  20. Martin CR, Dumas GJ, Shoaie C, Zheng Z, Mackinnon B, Al-Aweel I, Bistrian BR, Pursley DM, Driscoll DF. Incidence of hypertriglyceridemia in critically ill neonates receiving lipid injectable emulsions in glass versus plastic containers: a retrospective analysis. J Pediatr. 2008 Feb; 152(2):232-6.
    View in: PubMed
    Score: 0.011
  21. Driscoll DF. Globule-size distribution in injectable 20% lipid emulsions: Compliance with USP requirements. Am J Health Syst Pharm. 2007 Oct 01; 64(19):2032-6.
    View in: PubMed
    Score: 0.011
  22. Driscoll DF, Ling PR, Bistrian BR. Physical stability of 20% lipid injectable emulsions via simulated syringe infusion: effects of glass vs plastic product packaging. JPEN J Parenter Enteral Nutr. 2007 Mar-Apr; 31(2):148-53.
    View in: PubMed
    Score: 0.011
  23. Driscoll DF, Silvestri AP, Bistrian BR, Mikrut BA. Stability of total nutrient admixtures with lipid injectable emulsions in glass versus plastic packaging. Am J Health Syst Pharm. 2007 Feb 15; 64(4):396-403.
    View in: PubMed
    Score: 0.011
  24. Driscoll DF. Lipid injectable emulsions: Pharmacopeial and safety issues. Pharm Res. 2006 Sep; 23(9):1959-69.
    View in: PubMed
    Score: 0.010
  25. Driscoll DF. Lipid injectable emulsions: 2006. Nutr Clin Pract. 2006 Aug; 21(4):381-6.
    View in: PubMed
    Score: 0.010
  26. Driscoll DF, Silvestri AP, Nehne J, Kl?tsch K, Bistrian BR, Niemann W. Physicochemical stability of highly concentrated total nutrient admixtures for fluid-restricted patients. Am J Health Syst Pharm. 2006 Jan 01; 63(1):79-85.
    View in: PubMed
    Score: 0.010
  27. Parikh MJ, Dumas G, Silvestri A, Bistrian BR, Driscoll DF. Physical compatibility of neonatal total parenteral nutrient admixtures containing organic calcium and inorganic phosphate salts. Am J Health Syst Pharm. 2005 Jun 01; 62(11):1177-83.
    View in: PubMed
    Score: 0.009
  28. Driscoll DF. Stability and compatibility assessment techniques for total parenteral nutrition admixtures: setting the bar according to pharmacopeial standards. Curr Opin Clin Nutr Metab Care. 2005 May; 8(3):297-303.
    View in: PubMed
    Score: 0.009
  29. Driscoll M, Driscoll DF. Calculating aluminum content in total parenteral nutrition admixtures. Am J Health Syst Pharm. 2005 Feb 01; 62(3):312-5.
    View in: PubMed
    Score: 0.009
  30. Driscoll DF. Compounding TPN admixtures: then and now. JPEN J Parenter Enteral Nutr. 2003 Nov-Dec; 27(6):433-8; quiz 439.
    View in: PubMed
    Score: 0.008
  31. Driscoll DF. Sterility of fat emulsion in plastic syringes. Am J Health Syst Pharm. 2003 Jan 15; 60(2):197; author reply 198.
    View in: PubMed
    Score: 0.008
  32. Bonaterra GA, Driscoll D, Schwarzbach H, Kinscherf R. Krill Oil-In-Water Emulsion Protects against Lipopolysaccharide-Induced Proinflammatory Activation of Macrophages In Vitro. Mar Drugs. 2017 Mar 15; 15(3).
    View in: PubMed
    Score: 0.005
  33. Gramlich L, Meddings L, Alberda C, Wichansawakun S, Robbins S, Driscoll D, Bistrian B. Essential Fatty Acid Deficiency in 2015: The Impact of Novel Intravenous Lipid Emulsions. JPEN J Parenter Enteral Nutr. 2015 Sep; 39(1 Suppl):61S-6S.
    View in: PubMed
    Score: 0.005
  34. Vanek VW, Allen P, Harvey Banchik LP, Bistrian B, Collier S, Driscoll DF, Gura K, Houston DR, Miles J, Mirtallo J, Mogensen KM, Seidner D. Parenteral nutrition intravenous fat emulsions product shortage considerations. Nutr Clin Pract. 2013 Aug; 28(4):528-9.
    View in: PubMed
    Score: 0.004
  35. Martin CR, Dasilva DA, Cluette-Brown JE, Dimonda C, Hamill A, Bhutta AQ, Coronel E, Wilschanski M, Stephens AJ, Driscoll DF, Bistrian BR, Ware JH, Zaman MM, Freedman SD. Decreased postnatal docosahexaenoic and arachidonic acid blood levels in premature infants are associated with neonatal morbidities. J Pediatr. 2011 Nov; 159(5):743-749.e1-2.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.